Patient Safety

The Impact of Midazolam on Postoperative Nausea and Vomiting (PONV) and PACU Length of Stay in Patients Undergoing Cancer-Related Outpatient Surgery (.5 Class A CE with .5 Pharm)

Sunday, September 23
9:45 AM - 10:15 AM
Location: Room 312, Hynes

Despite the results of a meta-analysis supporting midazolam decreasing the incidence of PONV, published consensuses guidelines have only alluded to IV midazolam's potential for preventing PONV and have not formally recommended IV midazolam 1. Midazolam should be included in a multi-modal approach to reduce PONV in adults undergoing outpatient surgery especially in cancer-related surgeries.

Learning Objectives:

Jennifer E. Ross, MSN, CRNA

Nurse Anesthetist II
Memorial Sloan Kettering Cancer Center
Astoria, New York

Jennifer Ross, MSN, CRNA is a Certified Nurse Anesthetist at Memorial Sloan Kettering in New York, New York. She primarily works at the Josie Robertson Surgical Center, an innovative Outpatient Surgical Center that provides care for patients undergoing cancer-related surgeries. She is also pursuing her a PhD in Nursing at Catholic University focusing her research on interventions to reduce preoperative anxiety in women undergoing cancer-related breast surgeries. Ms. Ross was also previously a CRNA Clinical Faculty for Boston College’s Nurse Anesthesia program.

Presentation(s):

Send Email for Jennifer Ross

Christian Cansino, DNP, CRNA, FNP

Nurse Anesthetist
Memorial Sloan Kettering Cancer Center
Woodside, New York

Christian Cansino, DNP, CRNA, FNP is an assistant professor of clinical nursing at Columbia University in the nurse anesthesia program. He is also a staff nurse anesthetist at Memorial Sloan Kettering Cancer Center. His current research interests include postoperative nausea and vomiting in the cancer population, preceptorship of SRNAs in the clinical setting, and high fidelity simulation training for nurse anesthesia students.

Presentation(s):

Send Email for Christian Cansino


Assets

The Impact of Midazolam on Postoperative Nausea and Vomiting (PONV) and PACU Length of Stay in Patients Undergoing Cancer-Related Outpatient Surgery (.5 Class A CE with .5 Pharm)

Slides

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for The Impact of Midazolam on Postoperative Nausea and Vomiting (PONV) and PACU Length of Stay in Patients Undergoing Cancer-Related Outpatient Surgery (.5 Class A CE with .5 Pharm)